How Evox Therapeutics is targeting CNS diseases with exosomes
Our guest today is Dr. Per Lundin, CEO of Evox Therapeutics, a UK biotech using engineered exosomes to deliver genetic medicines directly into the brain. The post How Evox Therapeutics is targeting CNS diseases with exosomes appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s…
We haven't written up this one. Labiotech has the full story — the link below goes straight to it.